A 46-year-old man with advanced lung cancer recovered after doctors used Next Generation Sequencing to identify a rare ALK fusion mutation and treat him with targeted therapy instead of chemotherapy.
In a new trial, patients with B-acute lymphoblastic leukemia (B-ALL) who had no evidence of remaining cancer cells after prior treatment, experienced comparable outcomes whether they received ...
News Medical on MSN
Chemo, Radiation Equal for Pre-Transplant in B-ALL Patients
ORLANDO, Dec. 6, 2025) In a new trial , patients with B-acute lymphoblastic leukemia (B-ALL) who had no evidence of remaining cancer cells after ...
In a new trial, patients with B-acute lymphoblastic leukemia (B-ALL) who had no evidence of remaining cancer cells after ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results